Catalent Pharma Solutions LLC

  • Home
  • Catalent Pharma Solutions LLC

Catalent Pharma Solutions LLC Championing the missions that matter™. Catalent is your trusted partner in transforming lives. Catalyst + Talent. Our name combines these ideas. Catalent develops.

Every medicine, therapy, and product we help develop, manufacture, and deliver reflects our commitment to put patients first. From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success. With time-tested experience in development sciences, delivery technologies, and multi-modality manufacturing, Catalent supports the acceleration of development programs and the launch of more than a hundred new products every year. With our broad range of expert services we drive faster, more efficient development timelines to help you take more molecules to market and create more effective products. Catalent delivers. As the world leader in drug delivery innovations, we have a proven record of enhancing bioavailability, solubility and permeability, improving ease and route of administration, and increasing patient compliance for better treatments. Catalent supplies. Globally positioned to serve all your manufacturing and commercial packaging needs, we provide integrated solutions to take your product from design, to clinical trial, to plant, and to pharmacy.

18/09/2026

From formulation to final delivery, the right strategy can make all the difference in advancing a promising molecule toward patients.

This September, Catalent experts are joining industry conversations around some of today’s most complex drug delivery challenges, from solubility and bioavailability to particle engineering and inhalation.

See where we’ll be and connect with our experts throughout the month.

Where will we see you this September? Book a meeting with our team: https://ow.ly/wyi850ZPkYr

For poorly soluble APIs, the right particle engineering strategy can make a significant difference in drug performance a...
18/09/2026

For poorly soluble APIs, the right particle engineering strategy can make a significant difference in drug performance and the path to commercialization.

Explore Catalent’s expert content on the advantages of pharmaceutical micronization. From improving dissolution and bioavailability to addressing the specialized containment requirements of highly potent APIs, the resource examines how micronization can help overcome critical development and manufacturing challenges.

This article highlights the value of an integrated clinical-to-commercial approach, helping reduce technology transfer risk and support a more efficient path as programs scale.

Connect with the Catalent team at Contract Pharma, September 24–25 in New Brunswick, New Jersey, to discuss how our global particle engineering expertise can support your molecule from development through commercial manufacturing.

Read the article: https://ow.ly/Fenf50ZPe11

Want to accelerate your monoclonal antibody program from gene to GMP drug substance in as little as eight months?Catalen...
18/09/2026

Want to accelerate your monoclonal antibody program from gene to GMP drug substance in as little as eight months?

Catalent’s Rapid Antibody Gene-to-Drug Substance program combines the GPEx® Lightning cell line development platform with proven process development and U.S.-based GMP manufacturing to provide an integrated, scalable pathway to clinical supply.

Designed specifically for traditional IgG1 and IgG4 monoclonal antibodies, the platform helps emerging biopharma teams reduce development risk, streamline scale-up and progress toward IND and first-in-human milestones with greater confidence.

Download the fact sheet to learn how Catalent can help accelerate your antibody development program: https://ow.ly/UNsl50ZPcKO

Our President & CEO, Alessandro Maselli, will participate in this year's Endpoints 11 Awards, one of biotech's most anti...
18/09/2026

Our President & CEO, Alessandro Maselli, will participate in this year's Endpoints 11 Awards, one of biotech's most anticipated celebrations of innovation and entrepreneurship.

Hosted by Endpoints News, this event recognizes eleven of the industry's most promising startups and founders whose work is helping shape the future of healthcare.

As a long-time supporter of the event, Alessandro will provide opening remarks and join industry leaders in celebrating the innovators advancing the next generation of therapies for patients around the world.

Reserve your spot to attend in-person on Sep 24, or virtually on Sep 28: https://ow.ly/jlej50ZP86O

A big thank you to everyone who joined us at the World Bispecific Summit this week and a special thanks to Rachel Kravit...
18/09/2026

A big thank you to everyone who joined us at the World Bispecific Summit this week and a special thanks to Rachel Kravitz for sharing her expertise on enabling bispecific antibodies at mAb-like timelines.

The conversations continue next week, with our teams heading to BioProduction Congress and BioProcess International East.

Join us there for more expert insights!

17/09/2026

September is a busy month for Catalent’s teams as we connect with scientists, innovators, and industry leaders across biologics, peptides, analytical services, and advanced therapies.

Across these events, we look forward to exchanging insights on the challenges shaping the industry today and exploring how we can partner with you to move your mission forward.

Attending one of these events? Connect with us today: https://ow.ly/xMj650ZOP7T

As cell and gene therapies advance, the right development and manufacturing strategy can make all the difference in gett...
17/09/2026

As cell and gene therapies advance, the right development and manufacturing strategy can make all the difference in getting promising programs to patients efficiently.

Our latest eBook explores the growing strategic role of CDMOs in helping developers overcome complex supply chains, manufacturing challenges and evolving analytical requirements.

Discover the technologies and approaches shaping the next generation of CGT, from iPSC manufacturing and plasmid platforms to AAV potency evaluation and scalable development strategies.

Download now: https://ow.ly/qbqq50ZOcOM

17/09/2026

AI isn't a passing trend. It's here to stay. At Catalent, the bigger story isn't the technology; it’s what it delivers.

Used well, AI gives teams across development, manufacturing and supply better tools, deeper insights and greater efficiency to work smarter and raise the quality of everything they deliver.

That's the point President and CEO Alessandro Maselli made in his recent interview with The CEO Magazine - North America: AI is becoming a lasting part of how we work, and its real value lies in what it unleashes for the organization: more time for higher-order work and improved solutions for customers and patients.

Watch part four of this five-part video series below to hear more from Alessandro on the role and implementation of AI at Catalent.

Read the full CEO Magazine cover story here: https://ow.ly/Eua150ZOcxG

As nasal delivery moves beyond local therapies into rapid systemic delivery, emergency rescue and CNS-targeted treatment...
16/09/2026

As nasal delivery moves beyond local therapies into rapid systemic delivery, emergency rescue and CNS-targeted treatments, aligning formulation, device, analytical and manufacturing strategies early can be critical to success.

In our latest executive summary, Catalent experts Dr. Alan Watts and David Wilcox explore the evolving nasal delivery landscape and share practical CMC considerations to help reduce technical risk, support regulatory readiness and prepare products for scale-up.

Download here: https://ow.ly/EwvI50ZOmI4

16/09/2026

Every program starts with a mission that matters. At Catalent, we’re here to help champion it.

From overcoming development hurdles to preparing for commercial scale, our experts will be at CPHI Milan to discuss how Catalent can help simplify complexity and keep programs moving forward toward patients.

Stay tuned for more on where to find our experts and the topics they’ll be discussing throughout CPHI. We look forward to seeing you in Milan!

📍 CPHI Milan | Stand 10C1
📅 October 6–8

Book time with us now: https://ow.ly/cevk50ZOmpA

Address

NJ

Telephone

+17325376200

Website

Alerts

Be the first to know and let us send you an email when Catalent Pharma Solutions LLC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Catalent Pharma Solutions LLC:

Shortcuts

  • Want your business to be the top-listed Business?

Share